You need to be logged in to see the full monograph.

USE OF LORATADINE IN PREGNANCY

Date of issue: March 2026, Version: 4

bumps logo
A corresponding patient information leaflet on USE OF LORATADINE IN PREGNANCY is available.

Loratadine is a non-sedating antihistamine used for the symptomatic relief of allergic conditions, including rhinitis (hay fever) and chronic idiopathic urticaria.

The available published data do not suggest an increased risk of miscarriage, infant congenital malformation, stillbirth or preterm delivery following in utero exposure to loratadine in pregnancy, and do not provide convincing evidence of an association with small for gestational age infants. However, some of the available data are methodologically limited, meaning further research is required. There are no data regarding infant neurodevelopment following in utero exposure to loratadine.

If local topical therapy fails to control symptoms, oral antihistamines can be considered for use in pregnancy. Non-sedating antihistamines tend to be used first-line due to potential risks associated with maternal drowsiness, with cetirizine and loratadine generally being preferred due to a larger volume of reassuring human pregnancy data.

Exposure to loratadine at any stage of pregnancy would not usually be regarded as medical grounds for termination of pregnancy or any additional fetal monitoring. However, other risk factors may be present in individual cases which may independently increase the risk of adverse pregnancy outcome. Clinicians are reminded of the importance of consideration of such factors when performing case-specific risk assessments.

This is a summary of the full UKTIS monograph for health care professionals and should not be used in isolation. The full UKTIS monograph and access to any hyperlinked related documents is available to NHS health care professionals who are logged in.

If you have a patient with exposure to a drug or chemical and require assistance in making a patient-specific risk assessment, please telephone UKTIS on 0344 892 0909 to discuss the case with a teratology specialist.

If you would like to report a pregnancy to UKTIS please click here to download our pregnancy reporting form. Please encourage all women to complete an online reporting form.

Disclaimer: Every effort has been made to ensure that this monograph was accurate and up-to-date at the time of writing, however it cannot cover every eventuality and the information providers cannot be held responsible for any adverse outcomes of the measures recommended. The final decision regarding which treatment is used for an individual patient remains the clinical responsibility of the prescriber. This material may be freely reproduced for education and not for profit purposes within the UK National Health Service, however no linking to this website or reproduction by or for commercial organisations is permitted without the express written permission of this service. This document is regularly reviewed and updated. Only use UKTIS monographs downloaded directly from UKTIS.org to ensure you are using the most up-to-date version.